Sanofi (SNY) Long-Term Debt Repayments (2013 - 2025)

Sanofi has disclosed Long-Term Debt Repayments across 11 years of filings, most recently posting -$3.1 billion for Q4 2025.

• In Q4 2025, Long-Term Debt Repayments fell 325.66% year-over-year to -$3.1 billion; the TTM figure through Dec 2025 stood at -$10.5 billion (down 4.88% YoY), while the FY2025 annual figure was -$3.1 billion, down 320.26% from the prior year.
• Long-Term Debt Repayments came in at -$3.1 billion for Q4 2025 at Sanofi, down from -$717.0 million in the prior quarter.
• In the past five years, Long-Term Debt Repayments ranged from a high of -$717.0 million in Q4 2024 to a low of -$4.0 billion in Q4 2023.
• Average Long-Term Debt Repayments over 5 years is -$2.6 billion, with a median of -$2.8 billion recorded in 2022.
• Year-over-year, Long-Term Debt Repayments surged 81.91% in 2024 and sank 325.66% in 2025.
• Over 5 years, Long-Term Debt Repayments stood at -$2.6 billion in 2021, then decreased by 8.17% to -$2.8 billion in 2022, then slumped by 42.9% to -$4.0 billion in 2023, then surged by 81.91% to -$717.0 million in 2024, then plunged by 325.66% to -$3.1 billion in 2025.
• Per Business Quant data, the three most recent Long-Term Debt Repayments figures were -$3.1 billion in Q4 2025, -$717.0 million in Q4 2024, and -$4.0 billion in Q4 2023.